You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2024

Details for Patent: RE39264


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: RE39264
Title:Pharmaceutical combination
Abstract:The invention relates to pharmaceutical compositions for topical administration comprising a topically acceptable antiviral substance and an antiinflammatory glucocorticoid in a pharmaceutically acceptable carrier. The pharmaceutical composition can be used in the prophylactic and curative treatment of herpesvirus infections in mammals including man. The invention also relates to the use of a combination of a topically acceptable antiviral substance and an antiinflammatory glucocorticoid for the manufacture of a medicament for said prophylactic and curative treatment.
Inventor(s): Harmenberg; Johan (Stockholm, SE), Kristofferson; Ann Harriet Margareta (Sodertaklje, SE)
Assignee: Medivir AB (Huddinge, SE)
Application Number:10/771,259
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent RE39264: A Comprehensive Analysis

Introduction

When analyzing a patent, particularly one like United States Patent RE39264, it is crucial to delve into its scope, claims, and the broader patent landscape. This analysis helps in understanding the patent's validity, its protection scope, and its position within the intellectual property ecosystem.

What is United States Patent RE39264?

To begin with, it is important to identify the subject matter of the patent. However, since the specific details of RE39264 are not provided in the sources, we will use general principles to guide our analysis.

Patent Scope and Claims

Understanding Patent Claims

Patent claims are the most critical part of any patent application. They define the scope of the invention and what is protected by the patent. Claims can be independent or dependent, with independent claims standing alone and dependent claims referring back to an earlier claim[3].

Claim Types and Their Significance

  • Independent Claims: These claims define the invention without reference to any other claims. They are crucial as they set the broadest scope of protection.
  • Dependent Claims: These claims refer back to an earlier claim and narrow down the scope of protection. They often add specific details or limitations to the independent claims.

Analyzing Claims of RE39264

To analyze the claims of RE39264, one would typically review the patent specification and claims section. Here, you would identify:

  • Independent Claims: Determine the broad scope of protection.
  • Dependent Claims: Understand how these claims narrow down or add specificity to the independent claims.
  • Claim Language: Pay attention to the language used, as it can significantly impact the scope of protection.

Patent Landscape Analysis

Tracking Patents by Claims and Scope Concepts

Patent landscape analysis involves categorizing patents by their claims and broader scope concepts. This helps in identifying which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist[3].

Claim Coverage Matrix

A Claim Coverage Matrix is a tool used to map which patents and claims are protecting specific technologies. This matrix can help in identifying:

  • Protected Technologies: Which aspects of the technology are covered by the patent claims.
  • Gaps in Coverage: Areas where the current patent portfolio does not provide adequate protection.
  • Future Opportunities: Potential areas for future innovation and patent filings.

Interactive Claim Charts

Tools like ClaimScape® software generate interactive claim charts that help in reviewing patent coverage. These charts can be used by technical experts to determine if a particular scope concept is applicable to a target product or method, highlighting gaps in current coverage and future design opportunities[3].

Obviousness-Type Double Patenting (ODP)

Definition and Implications

ODP is a doctrine that prevents an inventor from securing a second, later-expiring patent for an invention that is not patentably distinct from an earlier patent. This is crucial in ensuring that the patent term is not extended unfairly[1][2].

Relevance to RE39264

If RE39264 is part of a family of patents, it is essential to check for ODP issues. This involves comparing the claims of RE39264 with those of other related patents to ensure they are patentably distinct. The Federal Circuit has emphasized that ODP analysis must consider the expiration dates of the patents, including any adjustments due to Patent Term Adjustment (PTA)[1][2].

Written Description and Enablement

Importance of Written Description

The written description requirement under 35 U.S.C. § 112 ensures that the patent specification adequately describes the invention. This is critical for determining the validity of the patent claims[2].

Enablement Requirement

The enablement requirement ensures that the specification provides enough information for a person of ordinary skill in the art to make and use the invention. Any claims that lack sufficient written description or enablement can be deemed invalid[2].

Inventorship and Ownership

Determining Inventorship

Inventorship is a critical aspect of patent law. The true inventors must be identified and listed in the patent application. Errors in inventorship, especially those made with deceptive intent, can render the patent unenforceable[5].

Impact on Patent Validity

Ensuring correct inventorship and ownership is vital for maintaining the validity of the patent. Any disputes or issues related to inventorship can affect the enforceability of the patent.

Key Takeaways

  • Patent Claims Analysis: Understanding the independent and dependent claims is crucial for determining the scope of protection.
  • Patent Landscape: Analyzing the broader patent landscape helps in identifying gaps and opportunities.
  • ODP Considerations: Ensuring that the patent does not violate ODP principles is essential for maintaining its validity.
  • Written Description and Enablement: The patent specification must adequately describe and enable the invention.
  • Inventorship and Ownership: Correct inventorship and ownership are vital for the patent's validity and enforceability.

FAQs

Q: What is the significance of independent claims in a patent? A: Independent claims define the broadest scope of protection for the invention and stand alone without reference to other claims.

Q: How does ODP affect patent validity? A: ODP prevents an inventor from securing a second, later-expiring patent for an invention that is not patentably distinct from an earlier patent, ensuring the patent term is not unfairly extended.

Q: Why is written description important in patent law? A: The written description ensures that the patent specification adequately describes the invention, which is crucial for determining the validity of the patent claims.

Q: What happens if there are errors in inventorship? A: Errors in inventorship, especially those made with deceptive intent, can render the patent unenforceable.

Q: How can a Claim Coverage Matrix help in patent analysis? A: A Claim Coverage Matrix helps in identifying which patents and claims are protecting specific technologies, highlighting gaps in coverage and future opportunities.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit[1].
  2. Allergan USA, Inc. v. MSN Laboratories Private Ltd. - United States Court of Appeals for the Federal Circuit[2].
  3. Patent Analytics - Schwegman, Lundberg & Woessner, P.A.[3].
  4. Determining Inventorship for US Patent Applications - Oregon State University[5].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent RE39264

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: RE39264

PCT Information
PCT FiledFebruary 02, 1996PCT Application Number:PCT/SE96/00124
PCT Publication Date:August 15, 1996PCT Publication Number: WO96/24355

International Family Members for US Patent RE39264

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0809498 ⤷  Subscribe CA 2010 00009 Denmark ⤷  Subscribe
European Patent Office 0809498 ⤷  Subscribe 10C0038 France ⤷  Subscribe
European Patent Office 0809498 ⤷  Subscribe SPC/GB10/012 United Kingdom ⤷  Subscribe
Argentina 002030 ⤷  Subscribe
Austria 262907 ⤷  Subscribe
Austria 421358 ⤷  Subscribe
Australia 4682196 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.